✦ LIBER ✦

Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells

✍ Scribed by Katri Köninki; Mark Barok; Minna Tanner; Synnöve Staff; Jukka Pitkänen; Päivikki Hemmilä; Joanna Ilvesaro; Jorma Isola

Book ID: 116335445
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 580 KB
Volume: 294
Category: Article
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2010.02.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

143 MicroRNA-224 and −375 in Trastuzumab

143 MicroRNA-224 and −375 in Trastuzumab and Lapatinib Acquired and Innate Resistant HER2 Positive Breast Cancer Cells

✍ Howe, K.; Eustace, A.J.; Souahli, S.; Browne, B.C.; Aherne, S.; Barron, N.; Wals 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Molecular mechanisms underlying IGF-I-in

Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells

✍ Yuhong Lu; Xiaolin Zi; Michael Pollak 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 450 KB

## Abstract The clinical usefulness of trastuzumab (Herceptin; Genentech, San Francisco, CA) in breast cancer treatment is limited by the rapid development of resistance. We previously reported that IGF‐I signaling confers resistance to the growth‐inhibitory actions of trastuzumab in a model system

152 Molecular Mechanisms and Cell Death

152 Molecular Mechanisms and Cell Death Pathways in Targeted Therapy-Resistant Breast Cancer

✍ Montaser, R.; Coley, H.M.; Crook, T.M.; Ajabnoor, G.A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Inactivation of Rac1 reduces Trastuzumab

Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells

✍ Yong Zhao; Zhishan Wang; Yiguo Jiang; Chengfeng Yang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 877 KB

Molecular mechanisms for aberrant expres

Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences

✍ Lu, AiPing; Gupta, Anu; Li, Cong; Ahlborn, Thomas E; Ma, YongSheng; Shi, Eric Y; 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 336 KB

Molecular mechanism of suppression of MD

Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-κB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells

✍ Tran Thi Hien; Hyung Gyun Kim; Eun Hee Han; Keon Wook Kang; Hye Gwang Jeong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

Multidrug resistance (MDR) is a major obstacle in cancer chemotherapy and its inhibition is an effective way to reverse cancer drug resistance. In the present study, we investigated that puerarin, a natural isoflavonoid from Pueraria lobata, down-regulated MDR1 expression in MCF-7/adriamycin (MCF-7/